Science raises $230 million for clinical and commercialization work
Source publication date
Summary
Science announced a completed $230 million Series C for PRIMA commercialization preparation, clinical programs and infrastructure.
Editorial view
Track clinical stage, manufacturing readiness and authorization scope alongside funding.
Evidence and limitations
March 2026 announcement. Financing is not marketing authorization or independent clinical validation.